LyondellBasell could align with a below-2°C pathway by 2030. The company aims to achieve carbon neutrality by 2050, with interim targets to cut Scope 1 and 2 emissions by 42% and Scope 3 emissions by 30% by 2030, from a 2020 baseline. However, total GHG emissions rose 7.6% between 2020 and 2024, driven by Scope 3 growth linked to higher production volumes. Achieving the planned reductions will therefore require accelerated mitigation measures and full delivery of planned mitigation initiatives.

In the best case scenario, BASF is expected to align with a 2°C pathway by 2030. The company’s pathway to 2030 is now better evidenced, supported by tangible actions in renewable sourcing, efficiency, and pilot-scale low-carbon technologies. However, reliance on post-2030 technological deployment, weak Scope 3.1 targets with incomplete coverage, and modest transition capex commitments mean that BASF is not aligned with a 1.5°C pathway.

Bayer is projected to align with a 2°C warming scenario by 2030. Emissions trends have been inconsistent year-on-year, and key downstream categories, such as product use, remain excluded from Scope 3 disclosures, resulting in a likely underestimation of Bayer’s climate footprint.

Incitec Pivot is on track for a 1.5°C pathway by 2030. While Incitec Pivot demonstrates credible initiatives, such as technological innovation and strategic partnerships, certain transparency gaps remain.

Toray aims for carbon neutrality by 2050 but is most likely heading towards a 2°C to 3°C scenario by 2030. Without stronger absolute reduction commitments, enhanced supply chain accountability, and clearer links between incentives and Net Zero goals, Toray appears unlikely to align with the more ambitious 1.5°C target.

This paper provides an overview for financial institutions of the most pertinent issues identified by Planet Tracker from the UN Biodiversity Conference (COP16) in Cali, Colombia. Topics range from the availability of nature transition plans, to who has responsibility for nature in government structures – it’s looking complicated, to the availability of nature data – or rather its processing and analysing. The struggle to finance countries’ nature and ecosystem services remained unresolved.

Report from Planet Tracker urges investors to address the financial risks associated with toxic chemicals, which are key drivers of environmental damage, as well as being responsible for chronic and acute impacts on human health.

The release of novel entities — artificial chemicals and other human-made pollutants — into the biosphere, has accelerated to a point that they have exceeded their planetary boundary, threatening the Earth operating system, along with humanity. Planet Tracker’s latest report, ‘Novel Entities – A Financial Time Bomb’, presents a detailed analysis of the risks of one of Earth’s nine boundaries, novel entities. The report highlights their risk to both human and planetary health and warns investors of the significant financial risk they face from not considering their potential impact.

On 9 September, in Brussels, former European Central Bank President Mario Draghi presented his report on the “The future of European competitiveness”. The document outlines the challenges that EU businesses face in being both productive and environmentally friendly. The Draghi report had been much anticipated and, following its launch, has generated intense debate among the range of stakeholders – especially on whether Europe’s ambitious climate targets and related policies are hindering EU economic growth. Planet Tracker and Carbon Tracker have identified four major points of discussion.

SABIC is expected to be on a 2°C pathway by 2030 according to analysis by Planet Tracker. The company aims for carbon neutrality by 2050, targeting a 20% reduction in Scope 1 and 2 GHG emissions by 2030 from a 2018 baseline. However, Planet Tracker’s analysis shows that SABIC lacks a specific Scope 3 emissions target, which accounts for 70% of its footprint, and therefore the company will miss the alignment with the latest Paris Agreement ambition.